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Objectives: To evaluate the risk of obstructive sleep apnea (OSA) in a primary care population of elderly
Nigerians and to determine its correlates.
Methods: Clinical and demographic data of 414 elderly individuals in a primary care clinic were obtained.
Their risk of OSA was estimated using Berlin questionnaire while Epworth sleepiness scale and the
Center for Epidemiologic Studies Depression Scale (CESD-10) were also administered.
Results: Of the 414 subjects, 96 (23.2%) met the criteria for a high risk for OSAwith a male to female ratio
of 1:1. Subjects at high OSA risk (high OSA risk group) were younger than those at low OSA risk (low OSA
risk group) (71.476.8 vs 73.677.7, p¼0.011). Mean body mass index (BMI, kg/m2) (27.375.8 vs
24.775.1, po0.001) and waist circumference (WC, cm) (90.7713.1 vs 86.5713.9, p¼0.011) were higher
in the high OSA risk group compared with the low OSA risk group. A total of 215 (51.9%) and 62 (15.0%)
subjects had clinically signiﬁcant depressive symptoms (CESD-10 scoreZ10) and excessive daytime
sleepiness (EDS), respectively. On regression, the odds of EDS, depressive symptoms, increased BMI and
younger age were signiﬁcantly higher in the high OSA risk group compared with the low OSA risk group.
Conclusions: High risk for OSA and depressive symptoms are common in our sample of elderly Nigerians.
Depressive symptoms, EDS, BMI and age independently predict high OSA risk in the elderly.
& 2016 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sleep-related disorders are common among the elderly. Studies
in large populations of older adults have reported prevalence of
sleep-related disturbances greater than 50% [1,2]. Obstructive
sleep apnea (OSA) is a breathing disorder of sleep that has gained
signiﬁcant recognition in recent years due to its associated mor-
bidity and mortality worldwide. Individuals suffering from ob-
structive sleep apnea have a higher prevalence of obesity, diabetes,
hypertension, dyslipidemia, metabolic syndrome and other related
chronic medical conditions [3–5]. There had been a dearth of dataduction and Hosting by Elsevier B
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iation of Sleep.from sub-Saharan Africa compared to the developed world in the
OSA literature until recently [6]. There is now an increase in efforts
in the direction of exploring factors that are related to the condi-
tion among various populations. The trend of recent research
ﬁndings seems to suggest that OSA might be more frequent than
had been previously reported in these populations [7–10]. This
justiﬁes the need for more research that will further elucidate
factors that are interrelated with the disorder more importantly
among different populations in developing countries.
The prevalence of OSA has been studied across diverse popu-
lations worldwide. In a review of the epidemiology of OSA, an
overall prevalence of 3–7% was reported across various countries,
with a higher prevalence among men (3–7%) compared with wo-
men (2–5%) [7]. It was reported that these cut across populations
in both the developing and the developed world. Among the fac-
tors that have been shown to be signiﬁcantly associated with an
increased risk of obstructive sleep disorders across diverse popu-
lations is advancing age. Several studies have replicated the.V. This is an open access article under the CC BY-NC-ND license
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plateaus at about 60 years [7]. This portends the need to critically
explore the prevalence of OSA and its associated factors in the
older adult population. Epidemiological data on OSA in the elderly
in sub-Saharan African populations are scarce. This study aimed at
quantifying the risk of OSA in a primary care population of elderly
Nigerians and to determine its correlates.2. Methods
This cross-sectional study was carried out at the outpatient
clinic of State Hospital, Ilesa between June and October 2014. Ilesa,
with a population of 212,225 as at 2006 [11], is one of the largest
cities in the state of Osun located in South-western Nigeria. The
outpatient clinic of the State Hospital, Ilesa, is one of the two
largest primary care clinics in the city of Ilesa serving the entire
population of Ilesa and some of the adjourning towns and villages.
2.1. Study population
The sample consisted of 414 consecutive community-living el-
derly men and women, aged 65–100 years. They were con-
secutively recruited from individuals who had been receiving
monthly ﬁnancial support from the Government of the state of
Osun, South-Western Nigeria under a scheme which provided a
monthly stipend to support their wellbeing.
2.2. Selection criteria
Ambulant, community-living black men and women of Niger-
ian extract, aged Z65 years who gave their informed consent
were consecutively enrolled. Non-ambulant, institutionalized and
individuals of non-Nigerian origin as well as those who were not
willing to participate in the study, were excluded. The eligibility of
the subjects was ﬁrst assessed by one of the investigators, a family
physician, before they were recruited.
2.3. Subject assessment
Informed consent was obtained from all the subjects partici-
pating in the study. The study questionnaires were then ad-
ministered to them by the investigators and trained research
assistants.
2.3.1. Demographic and clinical data
Sociodemographic data including age, sex, highest formal
educational level attained and ethnic group; while disease-related
variables including history of chronic medical conditions such as
hypertension, diabetes, dyslipidemia, coronary artery disease, in-
termittent claudication and chronic kidney disease were obtained.
Other variables obtained include smoking and alcohol history and
history of coffee and kolanut consumption. Sitting blood pressure
and anthropometric measures including weight and height were
measured. Body Mass Index (BMI), a measure of body adiposity,
was calculated using the formula weight (kg) divided by the
square of height (m2).
2.3.2. Evaluation of OSA risk
The risk of OSA was determined using the Berlin Questionnaire.
The Berlin Questionnaire has three categories. Category 1 has ﬁve
questions about snoring, Category 2 has three questions about
daytime somnolence, and Category 3 has one question about the
history of hypertension. In addition, the questionnaire also collects
information about age, gender, height, and weight (to calculate the
BMI). The overall score is based on the patient's response to eachof the three categories. The patients are classiﬁed as high risk for
OSA if two or more categories are positive and low risk if less than
two categories are positive. This tool has reasonable sensitivity
(68.9%), speciﬁcity (56.4%), and positive predictive value (77.9%)
[12]. It has been used previously among populations in Nigeria
[5,13].
2.3.3. Assessment of excessive daytime sleepiness
The Epworth Sleepiness Scale (ESS) is an effective instrument
used to measure average daytime sleepiness. The ESS differ-
entiates between average sleepiness and excessive daytime slee-
piness that requires intervention. The individual self-rates his/her
likelihood of dozing in eight different situations. Scoring of the
answers is 0–3, with 0 being “would never doze” and 3 being “high
chance of dozing”. A sum of 11 or more from the eight individual
scores reﬂects above normal daytime sleepiness and need for
further evaluation [14]. The validity and reliability of ESS has been
tested in different groups of individuals across the healthcare
continuum [4]. It has also been used previously among popula-
tions in Nigeria [13,15].
2.3.4. Assessment of depressive symptoms
The 10-item version of the Center for Epidemiologic Studies
Depression Scale (CESD-10) was used to evaluate the participants
for depression symptoms. The CESD-10 is a short-form scale with
10 items that is designed to identify depressive symptoms in the
general population and has been used extensively in general pa-
tient and older adult populations [16,17]. The CESD-10 has shown
good predictive accuracy across different studies (kappa, 0.84–
0.97) when compared with the full-length 20-item version of the
CESD [17]. A 4-point Likert scale ranging from “rarely” (scored 0) to
“all of the time” (scored 3), is used to score the responses giving a
summed total of 0–30. Responses to at least 9 of the items were
included in the analyses. Clinically relevant depressive symptoms
were deﬁned as CESD-10 score Z10.
2.4. Statistical analysis
Data analyses was done using the Statistical Package for the
Social Sciences (SPSS), version 16 (SPSS Inc., Chicago, IL, U.S.A.) and
presented as means7SD and frequencies and percentages. For
variables with normal distribution comparison between groups
was performed using independent t-test. Relationship between
categorical variables was assessed using chi-square test. A logistic
regression model was constructed using OSA risk status as the
dependent variable and variables that were signiﬁcantly related to
OSA risk on bivariate analysis as covariates. A 5% signiﬁcance level
(po0.05) was considered signiﬁcant.
2.5. Ethical clearance
Ethical clearance was obtained from the Ethics and Research
Committee of the Hospitals Management Board of the State of
Osun.3. Results
3.1. Demographic and clinical proﬁles of the subjects
Out of the 414 subjects who participated in the study, 349
(84.3%) were women. The ages of the subjects ranged from 65 to
102 years with a mean of 73.177.5 years. Majority of the subjects
(240, 59.4%) had no form of formal education. All were from the
Yoruba tribe and resided in Ilesa town. Habitual use of kolanut,
alcohol and tobacco was reported by 76 (18.8%), 62 (15.3%) and 28
Table 1.
Demographic and clinical characteristics of the study sample.
Characteristics Statistics
Age (years) (mean 7 SD) 73.177.5
Age group (years) n (%)
65–74
75–84
Z85
251 (60%)
135 (32.6)
28 (6.8)
Sex n (%)
 Male
 Female
65 (15.7)
349 (84.3)
Education n (%)
 Nil
 Primary
 Secondary
 Tertiary
240 (59.4)
108 (26.7)
33 (8.2)
23 (5.7)
Smoking n (%) 28 (7.0)
Alcohol n (%) 62 (15.3)
Coffee (n) (%) 20 (5.0)
Colanut (n) (%) 76 (18.8)
History of cardiovascular disease (n) (%)
 Hypertension
 Diabetes Mellitus
 Stroke
 Intermittent claudication
 Other
134 (33.3)
29 (7.2)
6 (1.5)
45 (11.6)
0 (0)
Migraine (n) (%) 4 (1.0)
Report of use of antidepressant 0 (0)
BMI (kg/m2) (mean7SD) 25.375.4
WC (cm) (mean7SD) 87.5713.8
SBP (mmHg) (mean7SD) 141.0725.3
DBP (mmHg) (mean7SD) 84.0713.8
Other: coronary artery disease, myocardial infarction, dyslipidaemia and chronic
Kidney Disease, WC waist circumference, BMI body mass index, SBP systolic blood
pressure, DBP diastolic blood pressure, CESD-10 10 item Center for Epidemiologic
Studies Depression scale, ESS Epworth sleepiness scale.
Table 2.
Demographic and clinical characteristics of the subjects by OSA risk status.
Characteristics OSA risk p value
Low risk High risk
Age (years) (mean 7 SD) 73.677.7 71.476.8 0.011
Age group (years) n (%)
 65–74
 75–84
 Z85
184 (73.3)
109 (80.7)
25 (89.3)
67 (26.7)
26 (19.3)
3 (10.7)
0.069
Gender n (%)
Male
Female
50 (83.9)
268 (76.8)
15 (23.1)
81 (23.4)
0.981
Education (%)
 No formal education
 At least basic education
184 (76.7)
127 (77.4)
56 (23.3)
37 (22.6)
0.856
Smoking n (%) 21 (6.8) 7 (7.6) 0.800
Alcohol n (%) 50 (16.1) 12 (12.9) 0.178
Coffee n (%) 16 (5.1) 4 (4.3) 0.757
Kolanut n (%) 61 (19.6) 15 (16.1) 0.451
History of cardiovascular disease
 Hypertension n (%) 99 (31.9) 35 (37.6) 0.306
 Diabetes mellitus n (%) 21 (6.8) 8 (8.6) 0.647
 Stroke n (%) 4 (1.3) 2 (2.2) 0.625
 Intermittent claudication n (%) 30 (10.1) 15 (16.3) 0.104
 Other n (%) 0 (0) 0 (0) –
Migraine n (%) 3 (1.0) 1 (1.1) 0.927
WC cm (mean7SD) 86.5713.9 90.7713.1 0.011
BMI (kg/m2) (mean7SD) 24.775.1 27.375.8 o0.001
BMI group n (%)
 Underweight
 Normal
 Overweight
 Obese
27 (96.4)
140 (80.9)
91 (75.2)
46 (62.2)
1 (3.6)
33 (19.1)
30 (24.8)
28 (37.8)
0.001
SBP(mmHg)(mean7SD) 141.9726.3 138.1721.2 0.207
DBP(mmHg)(mean7SD) 84.3714.2 83.1711.9 0.460
CESD-10 score (mean7SD) 9.775.2 13.475.6 o0.001
ESS score (mean7SD) 4.974.4 7.476.0 0.011
Other: coronary artery disease, myocardial infarction, dyslipidaemia and chronic
Kidney Disease, WC waist circumference, BMI body mass index, SBP systolic blood
pressure, DBP diastolic blood pressure, CESD-10 10 item Center for Epidemiologic
Studies Depression scale, ESS Epworth sleepiness scale.
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20 (5.0%). A total of 134 (33.3%) subjects had a history of hy-
pertension, while 29 (7.2%), 45 (11.6%) and 6 (1.5%) had a history of
diabetes mellitus, intermittent claudication and stroke respec-
tively. The study population had a mean systolic blood pressure
(SBP), diastolic blood pressure (DBP) and BMI of
141.0725.3 mmHg, 84.0713.8 mmHg and 25.375.4 kg/m2 re-
spectively (Table 1). While snoring was r1eported more frequently
by the male subjects (29.2% vs 15.5%, p¼0.004), witnessed apnea
(23.9% vs 12.9%, p¼0.055) and BMI 430 kg/m2 were more fre-
quent among the female subjects (21.0% vs 6.3%, p¼0.006). Over-
all, BMI was signiﬁcantly higher among the female subjects
(25.875.5 kg/m2) compared with the male subjects
(22.873.8 kg/m2) (po0.001). The male subjects were more likely
to report a past diagnosis of hypertension (43.8% vs 31.3%,
p¼0.052).
3.2. Proﬁles of OSA risk, EDS and depression of the study population
Of the 414 subjects participating in this study, 96 (23.2%) met
the Berlin questionnaire criteria indicating a high risk of (OSA)
with a male to female ratio of 1:1. Excessive daytime sleepiness
(ESS score Z11) was indicated in 62 (15.0%) of the subjects with a
mean ESS score of 5.474.9. A total of 215 (51.9%) of the subjects
had clinically signiﬁcant depressive symptoms (CESD-10 score
Z10). The mean score on the CESD-10 scale for clinically relevant
depressive symptoms was 10.675.5.3.3. Correlates of high risk for OSA
3.3.1. Demographic variables and the risk of OSA
There was no signiﬁcant gender difference between subjects
who had high OSA risk (high OSA risk group) and those with low
risk (low OSA risk group) (p¼0.643). However, the high OSA risk
group was younger compared with the low OSA risk group
(p¼0.011). The proportion of subjects in the high OSA risk group
decreased progressively as age increased, however, this was not
statistically signiﬁcant (p¼0.069). Other socio-demographic vari-
ables that were assessed did not relate signiﬁcantly with the risk
of OSA (Table 2).
3.3.2. Clinical variables and the risk of OSA
The high OSA risk group had higher mean body mass index
(BMI) (p¼0.011) and higher mean waist circumference (WC)
(90.7713.1 vs 86.5713.9, po0.001) compared to the low OSA
risk group. When the subjects were re-stratiﬁed into two BMI
groups (BMI Z25 kg/m2 and o25 kg/m2), the high OSA group had
a higher proportion of BMI Z25 kg/m2 compared with the low
OSA risk group (63.0% vs 45.1%, p o 0.001). Adjusting for gender,
Fig. 1. Comparison of the prevalence of EDS and depression between subjects with
high and low OSA risks.
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(po0.001) but disappeared in the male subjects (p¼0.104). Si-
milarly, when WC was categorized into normal and abnormal WC
categories, the high OSA risk group had a signiﬁcantly higher
proportion of subjects in the abnormal WC category (69.6% vs
56.7%, p¼0.029) (Fig. 1). Adjusting for gender, the difference was
sustained in the female subjects (p¼0.013) while it disappeared in
the male subjects (p¼0.887). None of the subjects reported use of
an antidepressant.
3.3.3. Excessive daytime sleepiness, depressive symptoms and the
risk of OSA
Subjects in the high OSA risk group were more likely to have
excessive daytime sleepiness (ESS score Z11) compared to the
low risk group (30.2% vs 10.4%, po0.001). Similarly, subjects in the
high OSA risk group were more likely to be depressed (CESD score
of Z10) compared with those in the low risk group (68.8% vs
46.9%, po0.001) (Fig. 1).
3.3.4. Logistic regression analysis
A logistic regression model was constructed using risk of OSA
as the dependent variable and age, gender, WC, excessive daytime
sleepiness (ESS score Z11), depressive symptoms (CESD-10 score
Z10) as covariates. All but WC emerged as independent predictors
of high OSA risk. When BMI was excluded from the model, all,
except WC emerged as independent predictors of high OSA risk
(Table 3).
The odds of excessive daytime sleepiness (EDS) in subjects in
the high OSA risk group were about 4 times compared with those
in the low OSA risk group (po0.001) Similarly, the odds of de-
pression in participants in the OSA high risk group were about
3 times compared with those in the low risk low risk group
(po0.001). Older age was also independently related to lower
odds OSA risk while BMI was associated with higher odds of OSA
risk. The association between WC and OSA risk disappeared uponTable 3.
Logistic regression of the predictors of high risk for OSA.
BMI included
Variable OR 95% CI p
Age 0.948 0.912–0.984
Gender 1.654 0.765–3.576
ESS Z11 3.930 1.881–6.941 o
CESD Z10 2.893 1.687–4.963 o
WC 1.037 0.499–2.155
BMI 425 kg/m2 2.011 1.047–3.862
ESS Epworth sleepiness scale, CESD-10 10 item Center for Epidemiologic Studies Depreregression (Table 3). When BMI was removed from the model (in
view of its inclusion in the estimation of OSA risk), the other
variables, except WC, were not substantially modiﬁed (Table 3).4. Discussions
4.1. Prevalence of high risk for OSA
In this primary care sample of elderly Nigerians, we found that
about one out of every four (23.2%) of individuals were at a high
risk for OSA. This is consistent with the ﬁndings of previous stu-
dies. In a large population-based study conducted in the United
States [18,19], 26% of adults were found to be at high risk of OSA. A
similar study found a prevalence of high risk for OSA of 2 out of
every 5 hospitalized adults aged 450 years and with a mean age
of 65 years [20]. In a sample of community-dwelling elderly in-
dividuals studied by Hoch et al. [21], a prevalence of 26% was re-
ported. Reports from the developing world also suggest a pre-
valence that falls within the range reported from the developed
world [22]. In spite of the differences in methodology in exploring
OSA risk and its related factors across various geographic regions
and ethnic groups, it has been noted that comparisons of several
epidemiologic studies have yielded similar prevalence rates [22].
4.2. Factors modifying the risk of OSA
4.2.1. Gender
In the present study, we found no signiﬁcant gender difference
in the risk of OSA while we found a male to female ratio of about
1:1. It is fairly well established that the risk, prevalence and se-
verity of OSA have a male preponderance in the general popula-
tion [23], however, these gender differences seem to disappear in
the older age bracket [24]. This has been attributed, partly, to
hormonal changes accompanying menopause which limited evi-
dence suggests favors increased odds of OSA [24]. The male gender
is under-represented in our study, constituting only 16.9% of the
study population; this may have reduced likelihood of en-
countering individuals with high OSA risk.
4.2.2. Age
Age was signiﬁcantly associated with OSA risk in this study
such that the high OSA risk group was younger than the low OSA
risk group. From evidence, it is generally held that the prevalence
of snoring, high risk for OSA and, indeed, of OSA, increases with
age, peaks in middle age and declines after age 65 years [18,25].
However, the relationship between age and OSA risk in the elderly
has not been commonly explored. Our ﬁnding is similar to that of a
study conducted in the Southern stroke belt of the United States
on a large sample with an age range of 49–93 years and a mean
age of 67.5 years [26]. In the study, the subjects who were at a high
risk for OSA were signiﬁcantly younger than the low risk subjects.BMI excluded
OR 95% CI p
0.005 0.944 0.912–0.984 0.003
0.201 1.801 0.842–3.855 0.130
0.001 3.565 1.910–6.655 o0.001
0.001 3.007 1.761–5.135 o0.001
0.922 1.680 0.945–2.988 0.077
0.036
ssion scale, WC waist circumference, BMI body mass index.
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valence of OSA after midlife [18].
4.2.3. Excessive daytime sleepiness
The prevalence of excessive daytime sleepiness (EDS) was high
in our sample (15.0%) with a signiﬁcantly higher prevalence in the
high OSA risk group (30.2%) compared with the low OSA risk
group (10.4%). When other factors were adjusted for, the odds of
having EDS was four fold higher in the high OSA group compared
with the low OSA group.
Excessive daytime sleepiness is common among elderly in-
dividuals [27,28] with a prevalence of about 15%. Several recent
reports have suggested that EDS could be a predictor of cognitive
decline and possibly, a harbinger of dementia in the elderly
[29,30]. It has also been linked to increased risk of poor functional
[31], psychosocial [32] and cardiovascular outcomes [33] and all-
cause mortality [34]. Excessive daytime sleepiness is consistently
reported as a strong association of OSA in the literature [35]. OSA
is characterized by upper airway obstruction with consequent
hypoxemia and sleep fragmentation; this leads to daytime som-
nolence and fatigue [36]. Excessive daytime sleepiness is such a
cardinal feature of OSA that the American Academy of Sleep
Medicine Task Force recommends an AHI Z5 associated with the
presence of symptoms such as excessive daytime sleepiness as a
criterion for OSA diagnosis [37].
4.2.4. Depressive symptoms
In this study, the prevalence of depression was slightly above
1 out of every 2 individuals with none reporting being on an an-
tidepressant agent. This is consistent with previous reports from
Nigeria which suggest that depressive disorders are common,
underdiagnosed and poorly treated with signiﬁcantly high unmet
needs for treatment in the older adult population in Nigeria
[38,39]. It is generally accepted that depression is not a normal
part of aging, however, the various medical conditions associated
with increasing age typically results in an increase in the risk of
depression in older adults [40,41].
Our analysis also showed that 2 out of every 3 subjects with a
high OSA risk had clinically signiﬁcant depressive symptoms.
When other factors were controlled for, the odds of depression in
the high OSA risk group was 3 that of the low risk group. The
association between depressive symptoms and OSA risk was
strong and independent. To the best of our knowledge, our study is
the ﬁrst study among populations of the aged in Nigeria to de-
scribe this relationship.
Our ﬁnding also mirrors reports from several previous studies
that have consistently demonstrated a high prevalence (5–63%) of
depression among individuals with OSA [42,43]. While the exact
pathophysiologic basis for the relationship between OSA and de-
pression appears to be elusive, various explanations for their co-
existence have been proposed. Firstly, the upper airway obstruc-
tion in OSA causes hypoxemia which results in sleep fragmenta-
tion which in turn causes excessive daytime sleepiness [36] with
associated poor cognitive function and low mood [44]. Secondly
and hypothetically, an abnormality in central and peripheral ser-
otonin neurotransmission which has been implicated in depres-
sion also interferes with the hypoglossal nerve, impeding genio-
glossus muscle activity and compromising the airway [45]. Fur-
thermore, a systematic review and meta-analysis of the results of
randomized controlled trials established that the treatment of OSA
with continuous positive airway pressure (CPAP) and mandibular
advancement devices have signiﬁcant and positive impact on de-
pression [46], suggesting that an association may exist between
OSA and depression. Nevertheless, the true nature of the interac-
tion between OSA and depression remains, largely, unclear [42].4.2.5. Adiposity and body fat distribution
We also found an association between BMI and WC and the risk
of OSA on bivariate analysis. This association disappeared for WC
on regression analysis but remained for BMI. As BMI increased, the
proportion of subjects at a high risk for OSA increased from 3.6% in
the underweight to 37.8% in the obese. This conﬁrms previous
studies which have repeatedly reported similar patterns [2]. In-
creased body adiposity is considered a strong risk factor for OSA.
In fact, according to meta-analysis, up to 85% of OSA patients who
underwent bariatric surgery had complete resolution of their
sleep-disordered breathing after surgery [47]. When we removed
BMI from the regression model, being one of the items in the
Berlin questionnaire, WC remained non-signiﬁcant in its con-
tribution to the model but other variables remained independent
in predicting OSA risk.
We found no association between hypertension and OSA risk in
this study; this may be due to the effect of age. Reports from large
population-based studies have indicated that a strong, graded
association exists between hypertension and the risk of OSA with
the prevalence of hypertension rising with increasing severity of
OSA [48,49]. However, this association is less prominent in the in
the elderly compared with younger individuals [48,49] and may be
a consequence of a reduction in cardiovascular response to sleep
arousal with increasing age [50].
4.3. Limitations
There are a few limitations which may reduce the general-
ization of our ﬁndings without negating the implication of our
results. Our study was conducted only in one center, comprising
mainly a tribe in Nigeria and excluding non-ambulant individuals.
Using self-report might bring about recall bias among subjects.
The subjects were however given adequate time to respond to the
items in the questionnaires. This was also a cross-sectional study
of the risk of OSA without objective sleep study. The Berlin ques-
tionnaire, in a recent study, demonstrated a low level of speciﬁcity
(39%) in discriminating OSA in elderly individuals [51]. There is,
therefore, a need for caution in ascribing causality to the asso-
ciated factors. The evidence regarding the inﬂuence of gender on
EDS and OSA risk in this study is further limited by the female
preponderance in our sample. This reﬂects the gender distribution
of the elderly population at the study site and not of the elderly
population in Nigeria or the State of Osun [11]. Therefore, the
ﬁndings from this study cannot be generalized to the elderly po-
pulation in Nigeria.5. Conclusions
The results of this study conﬁrm that the risks of OSA and
depression are high in the elderly. This study also provides evi-
dence that OSA has signiﬁcant negative impact on the mental
health of the elderly as a high OSA risk independently increases
the odds of depressive symptoms in them. As previously estab-
lished, a direct and independent association was also found be-
tween excessive daytime sleepiness, increased body adiposity and
increased risk of OSA. We also found that in people aged 65 years
and above, the risk of OSA decreases with age as opposed to what
has been documented in individuals under the age of 65 years.
Larger community-based, prospective studies in sub-Saharan
Africa are needed to conﬁrm the ﬁndings of this study.Acknowledgement
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